Search Results - "Nakao, Mitsushige"

Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma by Muramatsu, Ayako, Kobayashi, Tsutomu, Kawaji-Kanayama, Yuka, Uchiyama, Hitoji, Sasaki, Nana, Uoshima, Nobuhiko, Nakao, Mitsushige, Takahashi, Ryoichi, Shimura, Kazuho, Kaneko, Hiroto, Kiyota, Miki, Wada, Katsuya, Chinen, Yoshiaki, Hirakawa, Koichi, Fuchida, Shin-ichi, Shimazaki, Chihiro, Mizutani, Shinsuke, Tsukamoto, Taku, Shimura, Yuji, Taniwaki, Masafumi, Teramukai, Satoshi, Kuroda, Junya

“…Carfilzomib (CFZ) constitutes powerful combinatory therapy for relapsed/refractory multiple myeloma (RRMM); however, cardiovascular adverse events (CVAEs) have…”
Get full text

Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational study by Kawaji-Kanayama, Yuka, Muramatsu, Ayako, Sasaki, Nana, Shimura, Kazuho, Kiyota, Miki, Fuchida, Shinichi, Isa, Reiko, Fujino, Takahiro, Matsumura-Kimoto, Yayoi, Tsukamoto, Taku, Chinen, Yoshiaki, Mizutani, Shinsuke, Nakao, Mitsushige, Kaneko, Hiroto, Kawata, Eri, Hirakawa, Koichi, Takahashi, Ryoichi, Shimazaki, Chihiro, Uchiyama, Hitoji, Uoshima, Nobuhiko, Shimura, Yuji, Kobayashi, Tsutomu, Taniwaki, Masafumi, Kuroda, Junya

“…We conducted a post hoc analysis of our previous pilot observational study on the efficacy and safety of carfilzomib (CFZ)-containing therapy in 50 patients…”
Get full text

Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study by Mizuhara, Kentaro, Kobayashi, Tsutomu, Nakao, Mitsushige, Takahashi, Ryoichi, Kaneko, Hiroto, Shimura, Kazuho, Hirakawa, Koichi, Uoshima, Nobuhiko, Wada, Katsuya, Kawata, Eri, Isa, Reiko, Fujino, Takahiro, Tsukamoto, Taku, Mizutani, Shinsuke, Shimura, Yuji, Yoneda, Akiko, Watanabe, Akihide, Sotozono, Chie, Kuroda, Junya

“…Background Primary ocular adnexal mucosa‐associated lymphoid tissue (MALT) lymphoma (POAML) is the most common subtype of indolent ocular adnexal lymphomas…”
Get full text

Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patients by Sasaki, Nana, Shimura, Kazuho, Yoshida, Mihoko, Uoshima, Nobuhiko, Kiyota, Miki, Hatsuse, Mayumi, Uchiyama, Hitoji, Chinen, Yoshiaki, Kobayashi, Tsutomu, Nakao, Mitsushige, Takahashi, Ryoichi, Nakano-Akamatsu, Sonoko, Kaneko, Hiroto, Kobayashi, Yutaka, Shimazaki, Chihiro, Taniwaki, Masafumi, Kuroda, Junya

“…We retrospectively analyzed efficacy and safety of therapy with rabbit antithymocyte globulin (rATG) in combination with cyclosporine A (CsA) in 30 Japanese…”
Get full text

Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study by Matsumoto, Yosuke, Kobayashi, Tsutomu, Shimura, Yuji, Kawata, Eri, Nagoshi, Hisao, Ohshiro, Muneo, Sugitani, Mio, Shimura, Kazuho, Iwai, Toshiki, Fuchida, Shin-ichi, Yoshida, Mihoko, Kiyota, Miki, Mizutani, Shinsuke, Chinen, Yoshiaki, Takimoto-Shimomura, Tomoko, Nakao, Mitsushige, Kaneko, Hiroto, Uchiyama, Hitoji, Uoshima, Nobuhiko, Nishigaki, Hikari, Kobayashi, Yutaka, Horiike, Shigeo, Shimazaki, Chihiro, Taniwaki, Masafumi, Kuroda, Junya

“…This multicenter phase II study (UMIN000008145) aims to investigate the efficacy and safety of six cycles of combination therapy (RBD) comprising rituximab,…”
Get full text

Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib‐based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients by Kawaji‐Kanayama, Yuka, Kobayashi, Tsutomu, Muramatsu, Ayako, Uchiyama, Hitoji, Sasaki, Nana, Uoshima, Nobuhiko, Nakao, Mitsushige, Takahashi, Ryoichi, Shimura, Kazuho, Kaneko, Hiroto, Kiyota, Miki, Wada, Katsuya, Chinen, Yoshiaki, Hirakawa, Koichi, Fuchida, Shin‐ichi, Shimazaki, Chihiro, Matsumura‐Kimoto, Yayoi, Mizutani, Shinsuke, Tsukamoto, Taku, Shimura, Yuji, Horiike, Shigeo, Taniwaki, Masafumi, Kuroda, Junya

“…Background Combinatory strategies with carfilzomib (CFZ), a second‐generation proteasome inhibitor, plus dexamethasone (DEX) with or without lenalidomide (LEN)…”
Get full text

Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma by Tanba, Kazuna, Chinen, Yoshiaki, Uchiyama, Hitoji, Uoshima, Nobuhiko, Shimura, Kazuho, Fuchida, Shinichi, Kiyota, Miki, Nakao, Mitsushige, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Wada, Katsuya, Shimazaki, Chihiro, Kaneko, Hiroto, Kobayashi, Yutaka, Taniwaki, Masafumi, Kuroda, Junya

Get full text

Intravascular B-cell lymphoma with hypercalcemia as the initial presentation by Chinen, Yoshiaki, Nakao, Mitsushige, Sugitani-Yamamoto, Mio, Kiyota, Miki, Horiike, Shigeo, Kuroda, Junya, Taniwaki, Masafumi

“…Intravascular B-cell lymphoma (IVLBCL) is a rare subtype of extranodal diffuse large B-cell lymphoma, which is characterized by the growth of lymphoma cells…”
Get full text

Pulmonary Hemorrhage and Acute Renal Failure as an Initial Presentation of Multiple Myeloma by Morita, Yoshikata, Yasuda, Mako, Nakao, Mitsushige, Tsujimura, Yoshinori, Isono, Motohide

“…The combined clinical presentation of acute renal failure with pulmonary hemorrhage is known as pulmonary-renal syndrome. We describe a case of an 84-year-old…”
Get full text

VWRPY motif–dependent and –independent roles of AML1/Runx1 transcription factor in murine hematopoietic development by Nishimura, Motohiro, Fukushima-Nakase, Yoko, Fujita, Yasuko, Nakao, Mitsushige, Toda, Shogo, Kitamura, Nobuo, Abe, Tatsuo, Okuda, Tsukasa

“…AML1/Runx1 is a frequent target of leukemia-associated gene aberration, and it encodes a transcription factor essential for definitive hematopoiesis. We…”
Get full text

The Response to Second-line Induction with Bortezomib and Dexamethasone is Predictive of Long-term Outcomes Prior to High-dose Chemotherapy with Autologous Stem Cell Transplantation for Multiple Myeloma by Kobayashi, Tsutomu, Kuroda, Junya, Fuchida, Shin-ichi, Murakami, Satoshi, Hatsuse, Mayumi, Okano, Akira, Iwai, Toshiki, Tsutsumi, Yasuhiko, Kamitsuji, Yuri, Akaogi, Teruaki, Kawata-Iida, Eri, Shimizu, Daisuke, Uchiyama, Hitoji, Matsumoto, Yosuke, Horiike, Shigeo, Nakao, Mitsushige, Takahashi, Ryoichi, Kaneko, Hiroto, Uoshima, Nobuhiko, Kobayashi, Yutaka, Shimazaki, Chihiro, Taniwaki, Masafumi

“…Objective We retrospectively investigated the efficacy and predictive factors for the treatment outcomes of bortezomib plus dexamethasone (BD) as second-line…”
Get full text

RUNX1/AML1: A Central Player in Hematopoiesis by Okuda, Tsukasa, Nishimura, Motohiro, Nakao, Mitsushige, Fujitaa, Yasuko

Get full text

A New Prediction System for Platelet Recovery after Autologous Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphomas by Yamaguchi, Junko, Chinen, Yoshiaki, Uchiyama, Hitoji, Uoshima, Nobuhiko, Kaneko, Hiroto, Nakao, Mitsushige, Tsukamoto, Taku, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Kuroda, Junya

“…Transient thrombocytopenia is common after autologous peripheral blood stem cell transplantation (auto-PBSCT). Although patients underwent auto-PBSCT usually…”
Get full text

Acute myocardial infarction as the initial thrombotic event of thrombotic thrombocytopenic purpura by Takimoto, Tomoko, Nakao, Mitsushige, Nakajo, Takuya, Chinen, Yoshiaki, Kuroda, Junya, Taniwaki, Masafumi

“…Acquired thrombotic thrombocytopenic purpura (TTP) is characterized by the coemergence of microangiopathic hemolytic anemia, thrombocytopenia, and…”
Get full text

Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma by Chinen, Yoshiaki, Tanba, Kazuna, Takagi, Ryo, Uchiyama, Hitoji, Uoshima, Nobuhiko, Shimura, Kazuho, Fuchida, Shin-ichi, Kiyota, Miki, Nakao, Mitsushige, Tsukamoto, Taku, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Wada, Katsuya, Shimazaki, Chihiro, Kaneko, Hiroto, Kobayashi, Yutaka, Taniwaki, Masafumi, Yokota, Isao, Kuroda, Junya

“…Extended post-therapy long-term survival of patients with diffuse large B cell lymphoma (DLBCL) may also lead to an increase of late adverse events. We…”
Get full text

Prognostic Impact of Past History of Other Malignancies in Diffuse Large B Cell Lymphoma by Tanba, Kazuna, Chinen, Yoshiaki, Uchiyama, Hitoji, Uoshima, Nobuhiko, Shimura, Kazuho, Fuchida, Shin-ichi, Kiyota, Miki, Nakao, Mitsushige, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Wada, Katsuya, Shimazaki, Chihiro, Kaneko, Hiroto, Kobayashi, Yutaka, Taniwaki, Masafumi, Kuroda, Junya

“…Continual improvements of diagnosis and treatment methods for malignant tumors have improved the survival rates of cancer patients, and treatment strategy for…”
Get full text

Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma by Yamaguchi, Junko, Chinen, Yoshiaki, Takimoto-Shimomura, Tomoko, Nagata, Hiroaki, Muramatsu, Ayako, Kuriyama, Kodai, Ohshiro, Muneo, Hirakawa, Yoshiko, Iwai, Toshiki, Uchiyama, Hitoji, Uoshima, Nobuhiko, Kaneko, Hiroto, Nakao, Mitsushige, Tsukamoto, Taku, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Yokota, Isao, Kuroda, Junya

“…Delayed platelet engraftment (DPE) is occasionally observed despite prompt neutrophil engraftment after autologous peripheral blood stem cell transplantation…”
Get full text

Clinical manifestation and prognostic factors of 32 Japanese patients with autoimmune disease-associated diffuse large B-cell lymphoma by Maegawa, Saori, Kuroda, Junya, Kobayashi, Tsutomu, Fuchida, Shinichi, Kawata, Eri, Kamitsuji, Yuri, Tsutsumi, Yasuhiko, Iwai, Toshiki, Nakao, Mitsushige, Kaneko, Hiroto, Uoshima, Nobuhiko, Shimazaki, Chihiro, Kobayashi, Yutaka, Horiike, Shigeo, Yamamoto, Aihiro, Kawahito, Yutaka, Taniwaki, Masafumi

Get full text

RUNX1/AML1: a central player in hematopoiesis by Okuda, T, Nishimura, M, Nakao, M, Fujita, Y

“…It has been well established that a number of transcription factors play critical roles in regulating the fate of hematopoietic stem cell populations. One of…”
Get full text

Circadian chronotherapy with cisplatin and 5-fluorouracil in three patients with advanced gastric cancer by Taniwaki, Masafumi, Tomikashi, Kohichi, Sakai, Miki, Takada, Ryusuke, Ueda, Kyoji, Nakao, Mitsushige, Wakabayashi, Naoki, Mitsufuji, Shoji, Horiike, Shigeo, Kashima, Kei, Takeda, Sorho

Get more information